LONE STAR FUNDS acquires HILLENBRAND (2025)

Deal facts

Buyer: LONE STAR FUNDS
Target: HILLENBRAND
Deal value: Not disclosed
Announced: 12 November 2025
Status: In review
Sector: Other
Country: Not stated
Consideration: Not stated

Sources

EU_DG_COMP

What we know

Weekly digest

Join Exit Mode Insider

Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.

Join Exit Mode Insider, £12/mo

Deal timeline

1 update

4 Dec 2025CMA invitation to comment
LONE STAR FUNDS / HILLENBRAND
LONE STAR FUNDS / HILLENBRAND
EU DG COMP

OpinionExit Mode editorial

We see a significant shift in the industrial landscape as Lone Star Funds moves to acquire Hillenbrand. This transaction, announced on 12 November 2025, marks a classic private equity buyout of a listed entity. The deal remains in review, which signals that the transaction is not yet complete and is subject to standard regulatory and shareholder approvals. For the SME founder watching from the sidelines, this move underscores how private capital continues to target established industrial players, even when the specific sector falls under the broad 'Other' classification.

The mechanics of a deal of this nature inevitably trigger a rigorous scrutiny process. Because a public company is being taken private, the buyer must navigate complex change-of-control covenants and secure clearance from competition authorities. In the UK and EU context, this often means a CMA or European Commission review to ensure the consolidation does not stifle market competition. The absence of a stated value in the announcement is typical for deals still under review, as the final price often hinges on debt financing terms or regulatory conditions that have yet to be resolved. We view this as a calculated risk by the buyer, betting that the asset will clear these hurdles without significant dilution to the purchase price.

Our view is that the 'in review' status creates a period of uncertainty for the target company's management and workforce. The founder-reader should note that during this phase, operational decisions often freeze while legal teams dissect every clause. The deal type suggests a full exit rather than a partial sale, meaning the entire equity structure will likely change hands. This is not a merger of equals but a takeover where the buyer dictates the future governance. The lack of sector specificity in the data implies the target operates across multiple industrial verticals, which can complicate the regulatory assessment if any single vertical holds a dominant market share.

The immediate lesson for any founder considering a sale is to prepare for a prolonged review period before signing. You must ensure your commercial contracts allow for a clean break without triggering penalties that could derail the deal. This week, review your change-of-control provisions and identify any third-party consents you will need to secure before the regulator gives the green light. Do not assume the deal will close on the first attempt; build contingency plans for a timeline that extends well beyond the initial announcement.

Editorial opinion. Not financial or legal advice.

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

More Other deals More 2025 deals More pe acquisition deals More from LONE STAR FUNDS All M&A deals

Similar deals

Other Other M&A activity tracked by Exit Mode.

3 November 2024In reviewOther

Carlyle to acquire Corrohealth

Carlyle and Corrohealth entered the Exit Mode archive.

Buyer: Carlyle
Target: Corrohealth
Deal value: Not disclosed
Deal type: pe acquisition

Read deal Other deals pe acquisition deals In review deals

20 October 2024In reviewOther

CARLYLE to acquire VANTIVE

CARLYLE and VANTIVE entered the Exit Mode archive.

Buyer: CARLYLE
Target: VANTIVE
Deal value: Not disclosed
Deal type: pe acquisition

Read deal Other deals pe acquisition deals In review deals

15 October 2024In reviewOther

LONE STAR FUNDS to acquire CROWN

LONE STAR FUNDS and CROWN entered the Exit Mode archive.

Buyer: LONE STAR FUNDS
Target: CROWN
Deal value: Not disclosed
Deal type: pe acquisition

Read deal Other deals pe acquisition deals In review deals

27 April 2026In reviewIndustrials

LONE STAR FUNDS to acquire DOMO CHEMICALS ENGINEERING PLASTICS DIVISION

LONE STAR FUNDS and DOMO CHEMICALS ENGINEERING PLASTICS DIVISION entered the Exit Mode archive.

Buyer: LONE STAR FUNDS
Target: DOMO CHEMICALS ENGINEERING PLASTICS DIVISION
Deal value: Not disclosed
Deal type: unknown

Read deal Industrials deals unknown deals In review deals

13 April 2026In reviewIndustrials

LONE STAR FUNDS to acquire CAPSUGEL HOLDINGS US

Lone Star Funds has agreed to acquire Capsugel Holdings US on 13 April 2026. The transaction involves a target operating within the pharmaceutical manufacturing sector,…

Buyer: LONE STAR FUNDS
Target: CAPSUGEL HOLDINGS US
Deal value: Not disclosed
Deal type: unknown

Read deal Industrials deals unknown deals In review deals

Buyer history

LONE STAR FUNDS

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive

LONE STAR FUNDS to acquire HILLENBRAND

Deal facts

Join Exit Mode Insider

Deal timeline

Browse adjacent archives

Similar deals

Carlyle to acquire Corrohealth

CARLYLE to acquire VANTIVE

LONE STAR FUNDS to acquire CROWN

LONE STAR FUNDS to acquire DOMO CHEMICALS ENGINEERING PLASTICS DIVISION

LONE STAR FUNDS to acquire CAPSUGEL HOLDINGS US

LONE STAR FUNDS

How this page is built